Northern Trust Corp Novan, Inc. Transaction History

Northern Trust Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.05 - $2.04 $8,709 - $16,921	8,295 Added 32.12%	34,121 $44,000
Q1 2022 May 13, 2022	SELL	$2.95 - $4.41 $10,000 - $14,949	-3,390 Reduced 11.6%	25,826 $102,000
Q4 2021 Feb 08, 2022	BUY	$4.03 - $8.15 $9,160 - $18,524	2,273 Added 8.44%	29,216 $122,000
Q3 2021 Nov 15, 2021	SELL	$7.48 - $10.17 $6,911 - $9,397	-924 Reduced 3.32%	26,943 $219,000
Q2 2021 Aug 13, 2021	BUY	$7.8 - $17.35 $217,362 - $483,492	27,867 New	27,867 $280,000

Ticker NOVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,281,600
Market Cap $638K
Description
Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-sp...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.